Author: Jesse Landry

Quantum isn’t coming. It’s already in the room, wearing Colorado flannel and speaking in electro-optic amplifiers. And Bifrost Electronics just lit the signal fire straight from Arvada, $2.5 million in fresh seed funding to crack one of quantum’s oldest headaches wide open: readout. Now, let’s be clear, quantum readout isn’t sexy. It’s where the sausage gets made. But that’s exactly what makes it mission-critical. You can build the prettiest qubits in the world, but if you can’t read them with precision, scale them without noise, or integrate them without a headache, then you’ve just got Schrödinger’s paperweight. Bifrost isn’t here…

Straight out of Saratoga, California (not Menlo Park, get your geography right), Collate just locked in a $10M Series A. Led by Venrock, yes, the same house that backed Apple and Intel when the rest of the world was still figuring out floppy disks, this round isn’t about playing catch-up. It’s about building the metadata OS that the AI age actually needs. The co-founders? Not your typical hoodie-and-hustle duo. Suresh Srinivas (CEO) has 26 years of firepower behind him, ex-Chief Architect of Uber’s Data Platform and co-founder of Hortonworks, where Hadoop didn’t just get popular, it got enterprise. Then there’s…

Some founders build startups to exit. GT Medical Technologies was built to save lives, and maybe, just maybe, to make the phrase “inoperable brain tumor” obsolete. Let’s rewind to 2011. Five brain tumor specialists at Barrow Neurological Institute didn’t set out to disrupt. They set out to fix something. Radiation delays after brain surgery weren’t just inconvenient, they were lethal. So they built a better solution from scratch. In 2017, GT Medical Technologies was born to bring it to the world. This week? They just locked in a $53 million Series D that says they’re not just surviving, they’re scaling.…

There’s a difference between managing chaos and building a system that eats chaos for breakfast. CloudCover isn’t in the game to play tech janitor. They’re here to flip the switch on how infrastructure support actually works, from desktop to data center, continent to continent. And with a fresh growth investment led by Argentum Capital Partners, they’re not just scaling. They’re compounding. Founded in 2015 by Jeff Huggins and Roger Lindsay, CloudCover didn’t stumble into TPM. They saw the fragmentation early, the contract mess, the vendor bloat, the black hole of asset visibility. Most players placed platforms around services. CloudCover flipped…

You ever try threading a needle while riding a rollercoaster in the dark? That’s about the level of precision we’re talking when it comes to endoluminal surgery. Except now, EndoQuest Robotics just flipped on the headlights, and did it with a robotic assist. The Houston-based crew just locked in $39.66M in fresh Series D-2 funding, co-led by Crescent Enterprises and the godfather of surgical robotics himself, Dr. Fred Moll. This isn’t just another round. This is a war chest aimed squarely at the future of scar-free surgery. Let’s talk trajectory. Founded in 2017 as ColubrisMX and reborn in 2022 as…

Startups walk into the arena with a deck and a dream. Cogent Security showed up like they’ve been quietly rewriting the operating manual for cybersecurity, while everyone else was still patching Monday’s mess with Wednesday’s wisdom. Fresh out of stealth and already sitting on $11M in Series Seed from Greylock Partners (the same crew that incubated Palo Alto Networks, Abnormal Security, and backed Okta and Wiz), Cogent Security didn’t come to play. They came to fix the mess that vulnerability management has become, and to do it with something we haven’t seen before: an AI-native task force that acts like…

In a world where employer healthcare costs move like a runaway train, predictable in direction, disastrous in pace, The Difference Card didn’t try to stop the train. They rewired the tracks. Founded in 2001 and operated by EB Employee Solutions LLC, The Difference Card has spent two decades doing something most in the industry only claim: delivering actual savings. We’re talking $1.8 billion in cumulative client savings, and 19.6% average net savings in just year one. That’s not cost control. That’s cost judo, flipping healthcare spend on its back using leverage and timing. Now, with a fresh growth equity investment…

You know the healthcare system’s been bleeding out talent for years. Burnout, shortages, inefficiency, it’s like watching a cassette deck in a streaming world. But Cobionix? They’re not slapping a Band-Aid on the problem. They’re building the future, and this week, they just picked up another scalpel. On July 9, Cobionix locked in $3 million in fresh strategic funding. Led by TitletownTech, yes, the same VC firm powered by Microsoft and the Green Bay Packers, this round also brought in Lions Investment, Dr. Paul McBeth (who happens to be one of Canada’s top minds in trauma surgery and robotics), and…

When you start a jewelry business in your basement with two grand and a dream, no one’s betting on you except maybe your mom and your roommate. But when your chains end up around the necks of Justin Bieber, Cardi B, Snoop, Micah Parsons, and Kevin Durant, and when the NBA, NFL, MLB, NHL, NCAA, and DC Comics all cut licensing deals with you? Yeah, now everybody’s paying attention. That’s exactly how The GLD Shop went from Pittsburgh hustle to global muscle. Founded in 2015 by Christian Johnston and his childhood friend Dan Folger, GLD began as a “we want…

The U.S. corporate bond market moves like a heavyweight fight, slow, deliberate, and brutal if you’re stuck in the dark. Until BondCliQ walked in and flicked on the lights. Since 2016, this team hasn’t just been building software. They’ve been architecting the first consolidated central market system for U.S. corporate bonds. Real-time pretrade and posttrade data. No smoke, no mirrors. Just clarity in a market that’s operated more like a whisper network than a modern exchange. Think of it like putting a spotlight on $8 trillion of fixed-income action, finally showing institutional players what’s really happening under the hood. At…